Etoposide Capsules and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Etoposide Capsules and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etoposide
Brand name: VePesid, Etopophos, Toposar
Synonyms: Etoposide
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Etoposide Capsules-Insulin degludec
- Etoposide Capsules-Insulin Degludec (U-100) Prefilled Pens
- Etoposide Capsules-Insulin Degludec (U-100) Vials
- Etoposide Capsules-Insulin Degludec (U-200) Prefilled Pens
- Etoposide Capsules-Insulin degludec and liraglutide
- Etoposide Capsules-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Etoposide injection
- Insulin aspart, recombinant Subcutaneous-Etoposide Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Etoposide phosphate
- Insulin aspart, recombinant Subcutaneous-Etrafon
- Insulin aspart, recombinant Subcutaneous-Etrafon Forte
- Insulin aspart, recombinant Subcutaneous-Etravirine